Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial.

Articolo

Data di Pubblicazione:

2015

Citazione:

Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial / Bianchini, G; Pusztai, L; Pienkowski, T; Im, Yh; Bianchi, Gv; Tseng, Lm; Liu, Mc; Lluch, A; Galeota, E; Magazzù, D; de la Haba-Rodríguez, J; Oh, Dy; Poirier, B; Pedrini, Jl; Semiglazov, V; Valagussa, P; Gianni, L.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - (2015).

Tipologia CRIS:

1.1 Articolo in rivista

Elenco autori:

Bianchini, G; Pusztai, L; Pienkowski, T; Im, Yh; Bianchi, Gv; Tseng, Lm; Liu, Mc; Lluch, A; Galeota, E; Magazzù, D; de la Haba-Rodríguez, J; Oh, Dy; Poirier, B; Pedrini, Jl; Semiglazov, V; Valagussa, P; Gianni, L.

Autori di Ateneo:

BIANCHINI GIAMPAOLO

Link alla scheda completa:

https://iris.unisr.it/handle/20.500.11768/153898

Pubblicato in:

ANNALS OF ONCOLOGY

Journal